Europe cannot afford to lose the race for biomedical innovation
As clinical trials and investment increasingly turn elsewhere, European patients are missing out on breakthrough treatments. Policy can make a real difference here.
<p>As clinical trials and investment increasingly turn elsewhere, European patients are missing out on breakthrough treatments. Policy can make a real difference here.</p>